Monopar Therapeutics MNPR Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Monopar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monopar Therapeutics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monopar Therapeutics's common stock?
- Monopar Therapeutics (MNPR) reported common stock of $6.7K in Q1 2026.
- How has Monopar Therapeutics's common stock changed year-over-year?
- Monopar Therapeutics's common stock increased by 9.6% year-over-year, from $6.12K to $6.7K.
- What is the long-term trend for Monopar Therapeutics's common stock?
- Over 5 years (2020 to 2025), Monopar Therapeutics's common stock has grown at a -10.2% compound annual growth rate (CAGR), from $11.45K to $6.69K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).